Douma, Erik H.
Stoop, Jesse
Lingl, Matthijs V. R.
Smidt, Marten P.
van der Heide, Lars P. https://orcid.org/0000-0003-1779-425X
Funding for this research was provided by:
Dorpmans-Wigmans Stichting (WE.09-2017-03)
NWO Take-Off (WE.09-2017-03)
Article History
Received: 20 February 2024
Accepted: 14 October 2024
First Online: 25 October 2024
Declarations
:
: Not applicable.
: The Authors declare no competing non-financial Interests but the following competing financial interests: MPS and LPvdH are founders, CEO, and shareholders of Macrobian Biotech BV and Parkinnova Therapeutics BV.